Log In
BCIQ
Print this Print this
 

CGEN-15021

  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionFusion protein combining Fc with the extracellular region of a previously unknown membrane protein in the B7/CD28 family
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/18/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today